List of Tables
    Table 1. Endocrine Therapy Drugs for Breast Cancer Market Opportunities & Trends in Global Market
    Table 2. Endocrine Therapy Drugs for Breast Cancer Market Drivers in Global Market
    Table 3. Endocrine Therapy Drugs for Breast Cancer Market Restraints in Global Market
    Table 4. Key Players of Endocrine Therapy Drugs for Breast Cancer in Global Market
    Table 5. Top Endocrine Therapy Drugs for Breast Cancer Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Endocrine Therapy Drugs for Breast Cancer Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Endocrine Therapy Drugs for Breast Cancer Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Endocrine Therapy Drugs for Breast Cancer Product Type
    Table 9. List of Global Tier 1 Endocrine Therapy Drugs for Breast Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Endocrine Therapy Drugs for Breast Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Endocrine Therapy Drugs for Breast Cancer Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Endocrine Therapy Drugs for Breast Cancer Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Endocrine Therapy Drugs for Breast Cancer Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Endocrine Therapy Drugs for Breast Cancer Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2023-2028
    Table 30. Teva Corporate Summary
    Table 31. Teva Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 32. Teva Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 33. Amneal Pharms Corporate Summary
    Table 34. Amneal Pharms Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 35. Amneal Pharms Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 36. AstraZeneca Corporate Summary
    Table 37. AstraZeneca Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 38. AstraZeneca Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 39. Novartis Corporate Summary
    Table 40. Novartis Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 41. Novartis Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 42. Intas Pharmaceuticals Corporate Summary
    Table 43. Intas Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 44. Intas Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 45. Chemo Corporate Summary
    Table 46. Chemo Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 47. Chemo Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 48. Accure Labs Corporate Summary
    Table 49. Accure Labs Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 50. Accure Labs Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 51. Natco Corporate Summary
    Table 52. Natco Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 53. Natco Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 54. Zydus Pharmaceuticals Corporate Summary
    Table 55. Zydus Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 56. Zydus Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 57. Sanofi Corporate Summary
    Table 58. Sanofi Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 59. Sanofi Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 60. Pfizer Corporate Summary
    Table 61. Pfizer Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 62. Pfizer Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 63. Mylan  Corporate Summary
    Table 64. Mylan  Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 65. Mylan  Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 66. Wockhardt Corporate Summary
    Table 67. Wockhardt Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 68. Wockhardt Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 69. Cipla Corporate Summary
    Table 70. Cipla Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 71. Cipla Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 72. Actiza Pharmaceutical Corporate Summary
    Table 73. Actiza Pharmaceutical Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 74. Actiza Pharmaceutical Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 75. Hikma Pharmaceuticals Corporate Summary
    Table 76. Hikma Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 77. Hikma Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 78. Shanghai Forward Technology Corporate Summary
    Table 79. Shanghai Forward Technology Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 80. Shanghai Forward Technology Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 81. Bayer Corporate Summary
    Table 82. Bayer Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 83. Bayer Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 84. Liaoning Kangtai Pharmaceutical Corporate Summary
    Table 85. Liaoning Kangtai Pharmaceutical Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 86. Liaoning Kangtai Pharmaceutical Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 87. Fu 'an Pharmaceutical Group Corporate Summary
    Table 88. Fu 'an Pharmaceutical Group Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 89. Fu 'an Pharmaceutical Group Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 90. Apotex Corporate Summary
    Table 91. Apotex Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 92. Apotex Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 93. Taro Corporate Summary
    Table 94. Taro Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 95. Taro Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 96. Sun Phamaceutical Corporate Summary
    Table 97. Sun Phamaceutical Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 98. Sun Phamaceutical Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 99. Intas Pharmaceuticals Corporate Summary
    Table 100. Intas Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 101. Intas Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 102. Chemo Corporate Summary
    Table 103. Chemo Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 104. Chemo Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 105. Accure Labs Corporate Summary
    Table 106. Accure Labs Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 107. Accure Labs Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
    Table 108. Sun Pharmaceutical Corporate Summary
    Table 109. Sun Pharmaceutical Endocrine Therapy Drugs for Breast Cancer Product Offerings
    Table 110. Sun Pharmaceutical Endocrine Therapy Drugs for Breast Cancer Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Endocrine Therapy Drugs for Breast Cancer Segment by Type in 2021
    Figure 2. Endocrine Therapy Drugs for Breast Cancer Segment by Application in 2021
    Figure 3. Global Endocrine Therapy Drugs for Breast Cancer Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Endocrine Therapy Drugs for Breast Cancer Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Endocrine Therapy Drugs for Breast Cancer Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Endocrine Therapy Drugs for Breast Cancer Revenue in 2021
    Figure 8. By Type - Global Endocrine Therapy Drugs for Breast Cancer Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Endocrine Therapy Drugs for Breast Cancer Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Endocrine Therapy Drugs for Breast Cancer Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Endocrine Therapy Drugs for Breast Cancer Revenue Market Share, 2017-2028
    Figure 12. US Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Endocrine Therapy Drugs for Breast Cancer Revenue Market Share, 2017-2028
    Figure 16. Germany Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2028
    Figure 17. France Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Endocrine Therapy Drugs for Breast Cancer Revenue Market Share, 2017-2028
    Figure 24. China Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2028
    Figure 28. India Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Endocrine Therapy Drugs for Breast Cancer Revenue Market Share, 2017-2028
    Figure 30. Brazil Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Endocrine Therapy Drugs for Breast Cancer Revenue Market Share, 2017-2028
    Figure 33. Turkey Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Endocrine Therapy Drugs for Breast Cancer Revenue, (US$, Mn), 2017-2028
    Figure 37. Teva Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Amneal Pharms Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. AstraZeneca Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Novartis Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Intas Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Chemo Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Accure Labs Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Natco Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Zydus Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Sanofi Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Pfizer Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Mylan  Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Wockhardt Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Cipla Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 51. Actiza Pharmaceutical Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 52. Hikma Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 53. Shanghai Forward Technology Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 54. Bayer Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 55. Liaoning Kangtai Pharmaceutical Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 56. Fu 'an Pharmaceutical Group Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 57. Apotex Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 58. Taro Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 59. Sun Phamaceutical Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 60. Intas Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 61. Chemo Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 62. Accure Labs Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 63. Sun Pharmaceutical Endocrine Therapy Drugs for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)